시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
무표지 검출 시장 분석과 예측 : 유형, 제품, 기술, 용도, 최종 사용자, 컴포넌트, 기능, 디바이스, 기기, 솔루션(-2034년)
Label Free Detection Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Component, Functionality, Device, Equipment, Solutions
상품코드 : 1711643
리서치사 : Global Insight Services LLC
발행일 : 2025년 04월
페이지 정보 : 영문 321 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,541,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 7,918,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,296,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

무표지 검출 시장은 2024년 18억 달러에 달했고, 2034년까지는 42억 달러, 8.8%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상합니다. 의약품 및 생명과학 연구에 필수적인 실시간 모니터링 및 정량 분석을 제공합니다.

시장 개요

무표지 검출 시장은 주로 선진적인 신약 개발 프로세스에 대한 수요 증가로 강력한 성장을 이루고 있습니다. 제공하는 뛰어난 기능으로 이 시장을 독점하고 있습니다. 이 부문의 이점은 정확성과 효율성이 가장 중요시되는 제약 업계 및 생명 공학 업계에서 광범위하게 응용되고 있기 때문입니다. 레이트리더와 같은 새로운 하위 부문은 그 감도의 향상과 복잡한 생물학적 상호작용을 분석하는 능력에 의해 인기를 끌고 있습니다. 시장에 큰 영향을 미칠 것으로 보입니다. 또한 인공지능과 머신러닝과 무표지 검출 기술의 통합은 보다 정확한 데이터 분석을 제공하고 다양한 과학 분야에서의 응용 범위를 확대함으로써 미래의 성장을 가속할 것으로 예측됩니다.

시장 세분화
유형 광학, 전기화학, 질량분석, 음향, 열
제품 장비, 소모품, 소프트웨어
서비스 설치, 유지 보수, 컨설팅, 교육
기술 표면 플라즈몬 공명, 생체층 간섭법, 등온 적정 열량 측정, 시차 주사 열량 측정
용도 신약, 유전학, 단백질체학, 생명 공학, 제약, 진단학
최종 사용자 제약회사, 생명공학기업, 연구소, 학술기관, 위탁연구기관
구성요소 센서, 검출기, 마이크로플레이트
프로세스 실시간 분석, 높은 처리량 스크리닝
장비 벤치탑, 휴대용

무표지 검출 시장은 주로 바이오센서 기반의 기술이 지배적이며 광학 및 질량분석법도 큰 비율을 차지하고 있습니다.

GE Healthcare, Danaher Corporation, PerkinElmer 등 주요 기업은 전략적 제휴와 기술 혁신을 통해 적극적으로 포트폴리오를 강화하고 있습니다. 인공지능과 머신러닝과 같은 선진기술의 통합으로 검출 능력과 데이터 분석의 강화가 약속되어 시장의 확대가 기대됩니다.

주요 동향 및 촉진요인 :

무표지 검출 시장은 기술의 진보와 효율적인 신약 수법에 대한 수요가 높아짐에 따라 강력한 성장을 이루고 있습니다.

또 다른 중요한 추진력은 종종 비용과 시간이 많이 걸리는 표지 분석에 대한 의존성을 줄이는 것이 중요하다는 점입니다.

게다가 학술기관 및 연구기관에 있어서의 연구활동의 활성화가 무표지 검출 시스템 수요를 뒷받침하고 있습니다. 모니터링 및 식품 안전에 대한 라벨이 없는 기술의 응용 확대는 시장 성장을 더욱 강화하고 있습니다.

억제요인과 도전 :

무표지 검출 시장에는 몇 가지 중요한 억제요인과 과제가 있습니다. 이러한 기술은 복잡하기 때문에 전문적인 교육과 전문 지식이 필요하며, 필요한 리소스와 숙련된 인력을 가진 조직에 대한 도입이 제한됩니다. 확립된 라벨 기반의 검출법과의 경쟁입니다. 또한, 이 분야에서의 기술 진보의 속도가 빠르기 때문에 연구개발에의 지속적인 투자가 필요해, 기업의 재정 부담이 되고 있습니다. 컴플라이언스 요구 사항이 심한 지역에서는 라벨이 없는 감지 기술 시장 진입과 확장을 복잡하게 할 수 있습니다.

목차

제1장 무표지 검출 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 무표지 검출 시장 전망

제5장 무표지 검출 시장 전략

제6장 무표지 검출 시장 규모

제7장 무표지 검출 시장 : 유형별

제8장 무표지 검출 시장 : 제품별

제9장 무표지 검출 시장 : 서비스별

제10장 무표지 검출 시장 : 기술별

제11장 무표지 검출 시장 : 용도별

제12장 무표지 검출 시장 : 최종 사용자별

제13장 무표지 검출 시장 : 컴포넌트별

제14장 무표지 검출 시장 : 프로세스별

제15장 무표지 검출 시장 : 기기별

제16장 무표지 검출 시장 :지역별

제17장 경쟁 구도

제18장 기업 프로파일

SHW
영문 목차

영문목차

Label Free Detection Market is anticipated to expand from $1.8 billion in 2024 to $4.2 billion by 2034, growing at a CAGR of approximately 8.8%. The market encompasses technologies that enable the analysis of biomolecular interactions without the use of fluorescent or radioactive labels. These methods, including surface plasmon resonance and bio-layer interferometry, offer real-time monitoring and quantitative analysis, crucial for drug discovery and life sciences research. The market is driven by the need for cost-effective, accurate, and high-throughput solutions, with increasing applications in pharmaceuticals, biotechnology, and academic research institutions. Technological advancements and the demand for personalized medicine further propel market growth.

Market Overview

The Label Free Detection Market is experiencing robust growth, primarily driven by the increasing demand for advanced drug discovery and development processes. The biosensor-based technology segment dominates this market, owing to its superior capabilities in providing real-time and high-throughput analysis without the need for labels or dyes. This segment's dominance is further attributed to its broad application across pharmaceutical and biotechnology industries, where precision and efficiency are paramount. Emerging sub-segments such as optical biosensors and microplate readers are gaining traction due to their enhanced sensitivity and ability to analyze complex biological interactions. These innovations are poised to significantly impact the market by enabling more comprehensive and rapid analysis, thus accelerating research timelines. Furthermore, the integration of artificial intelligence and machine learning with label-free detection technologies is anticipated to drive future growth, offering more accurate data interpretation and expanding the scope of applications across various scientific disciplines.

Market Segmentation
TypeOptical, Electrochemical, Mass Spectrometry, Acoustic, Thermal
ProductInstruments, Consumables, Software
ServicesInstallation, Maintenance, Consulting, Training
TechnologySurface Plasmon Resonance, Bio-layer Interferometry, Isothermal Titration Calorimetry, Differential Scanning Calorimetry
ApplicationDrug Discovery, Genomics, Proteomics, Biotechnology, Pharmaceutical, Diagnostics
End UserPharmaceutical Companies, Biotechnology Firms, Research Laboratories, Academic Institutions, Contract Research Organizations
ComponentSensors, Detectors, Microplates
ProcessReal-time Analysis, High-throughput Screening
EquipmentBenchtop, Portable

The label-free detection market is primarily dominated by biosensor-based technologies, with optical and mass spectrometry methods also holding significant portions. This distribution is propelled by the rising demand for high-throughput screening and real-time analysis in drug discovery and development. North America currently leads the market, driven by robust research and development activities, while the Asia-Pacific region is witnessing accelerated growth due to increasing investments in biotechnology and pharmaceutical sectors.

Key players such as GE Healthcare, Danaher Corporation, and PerkinElmer are actively enhancing their portfolios through strategic collaborations and technological innovations. Regulatory frameworks, particularly in North America and Europe, are crucial in shaping the market landscape by ensuring compliance and safety standards. Looking forward, the market is expected to expand with the integration of advanced technologies like artificial intelligence and machine learning, which promise to enhance detection capabilities and data analysis. Challenges such as high instrument costs and the need for skilled personnel remain, yet ongoing advancements and the increasing focus on personalized medicine present significant growth prospects.

Recent Developments:

The Label Free Detection Market has experienced noteworthy developments recently. Thermo Fisher Scientific announced a strategic partnership with a leading biotech firm to enhance its label-free detection technologies, focusing on expanding applications in drug discovery. In a significant merger, two prominent companies in the label-free detection space, Bio-Rad Laboratories and Sartorius, have joined forces to drive innovation and expand their global market presence. Agilent Technologies launched a new label-free detection platform, promising enhanced sensitivity and speed, aimed at revolutionizing the screening processes in pharmaceutical research. The market has also seen a regulatory update, with the European Medicines Agency issuing new guidelines that streamline the approval process for label-free detection technologies, potentially accelerating market growth. Lastly, PerkinElmer reported a substantial increase in their label-free detection segment's revenue, attributing growth to increased demand from the biopharmaceutical industry and recent technological advancements. These developments underscore the market's dynamic nature and its growing importance in the life sciences sector.

Key Trends and Drivers:

The Label Free Detection Market is experiencing robust growth, driven by technological advancements and the increasing demand for efficient drug discovery methods. Key trends include the integration of advanced biosensors and real-time analysis technologies, which enhance the accuracy and speed of detection processes. This trend is particularly evident in pharmaceutical and biotechnology sectors, where rapid and precise analysis is crucial for innovation.

Another significant driver is the growing emphasis on reducing the reliance on labeled assays, which are often costly and time-consuming. Label-free technologies offer a cost-effective alternative, enabling real-time monitoring without the need for fluorescent or radioactive labels. This shift is supported by the rising adoption of personalized medicine, which demands more rapid and flexible diagnostic tools.

Furthermore, increasing research activities in academic and research institutions are propelling the demand for label-free detection systems. These institutions are focusing on new drug development and biomarker discovery, creating lucrative opportunities for market players. Additionally, the expanding applications of label-free technologies in environmental monitoring and food safety further fuel market growth. Companies investing in innovative solutions and expanding their application areas are poised to gain a competitive edge in this evolving market landscape.

Restraints and Challenges:

The Label Free Detection Market encounters several significant restraints and challenges. A primary challenge is the high cost of sophisticated label-free detection instruments, which can be prohibitive for smaller laboratories and research institutions. Additionally, the complexity of these technologies requires specialized training and expertise, limiting their adoption to organizations with the necessary resources and skilled personnel. Another challenge is the competition from established label-based detection methods, which are often more familiar and trusted by end-users. Furthermore, the rapid pace of technological advancement in the field necessitates continuous investment in research and development, placing financial strain on companies. Lastly, regulatory hurdles and varying international standards can complicate the market entry and expansion for label-free detection technologies, particularly in regions with stringent compliance requirements. These challenges collectively impede the broader adoption and growth of label-free detection solutions across diverse sectors.

Key Companies:

Bio- Rad Laboratories, Biacore, Forte Bio, Attana, Corning Incorporated, Pall Corporation, Perkin Elmer, Horiba, Malvern Panalytical, GE Healthcare, Bruker Corporation, Agilent Technologies, Shimadzu Corporation, Molecular Devices, Sartorius, Roche Diagnostics, Nanotemper Technologies, Wyatt Technology, TTP Labtech, Creoptix

Sources:

U.S. Food and Drug Administration - Center for Devices and Radiological Health, National Institutes of Health - National Center for Advancing Translational Sciences, European Medicines Agency, World Health Organization - Department of Essential Medicines and Health Products, International Society for Label-Free Detection, American Chemical Society - Division of Analytical Chemistry, International Conference on Label-Free Technologies, Society for Laboratory Automation and Screening, International Union of Pure and Applied Chemistry, National Institute of Standards and Technology, European Federation of Pharmaceutical Industries and Associations, Biotechnology Innovation Organization, International Society for Optical Engineering, American Association for the Advancement of Science, Institute of Electrical and Electronics Engineers - Engineering in Medicine and Biology Society, Massachusetts Institute of Technology - Institute for Medical Engineering and Science, Stanford University - Bio-X Program, University of California, Berkeley - Berkeley Sensor & Actuator Center, Harvard University - Wyss Institute for Biologically Inspired Engineering, Johns Hopkins University - Institute for NanoBioTechnology

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Label Free Detection Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Label Free Detection Market Outlook

5: Label Free Detection Market Strategy

6: Label Free Detection Market Size

7: Label Free Detection Market, by Type

8: Label Free Detection Market, by Product

9: Label Free Detection Market, by Services

10: Label Free Detection Market, by Technology

11: Label Free Detection Market, by Application

12: Label Free Detection Market, by End User

13: Label Free Detection Market, by Component

14: Label Free Detection Market, by Process

15: Label Free Detection Market, by Equipment

16: Label Free Detection Market, by Region

17: Competitive Landscape

18: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기